After her late husband's ALS diagnosis, columnist Juliet Taylor connected with other caregivers who provided support and ...

NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

Columnist Kristin Neva writes that, with her husband's ALS, it feels like they're living in the middle of a long story with no resolution.

Certain subsets of immune NK cells were altered in the blood of people with ALS, and could serve as therapeutic targets, a ...

Scientists have developed a new method that can grow motor neurons from skin cells, which may serve as a platform for ALS ...

With ALS, columnist Dagmar Munn often has trouble using plastic bottles, but she's found a few strategies for navigating ...

Neurosense reports Canadian regulators want a meeting that could lead to PrimeC's conditional approval there, and further ...

Signaling at the low-density lipoprotein receptor, known as LDLR, may be an important driver of neurodegeneration in sporadic amyotrophic lateral sclerosis (ALS), according to new preclinical research ...

Anita lives in England, near Bristol. She is a retired science teacher. She taught chemistry at secondary level for 30 years ...